111 related articles for article (PubMed ID: 4713416)
1. [Hypersexuality and L dopa].
Gisselmann A
Nouv Presse Med; 1973 Jun; 2(23):1616. PubMed ID: 4713416
[No Abstract] [Full Text] [Related]
2. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
Mones RJ; Elizan TS
J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
[No Abstract] [Full Text] [Related]
3. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
Lewis I
J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
[No Abstract] [Full Text] [Related]
4. [L-Dopa in parkinsonism, myth or reality].
Henry P
Bord Med; 1970 Feb; 3(2):393-7. PubMed ID: 5425873
[No Abstract] [Full Text] [Related]
5. [Factors which influence infavourably l-dopa treatment].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2115-6. PubMed ID: 4590071
[No Abstract] [Full Text] [Related]
6. [Aspects of hypersexuality observed in parkinsonian patients treated by L-dopa].
Ballivet J; Marin A; Gisselmann A
Ann Med Psychol (Paris); 1973 Nov; 2(4):515-22. PubMed ID: 4799646
[No Abstract] [Full Text] [Related]
7. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
[No Abstract] [Full Text] [Related]
8. [Theray of Parkinson-syndrome with Helfo-Dopa].
Roeder F
Med Klin; 1970 Nov; 65(45):1983-7. PubMed ID: 5520307
[No Abstract] [Full Text] [Related]
9. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
Lhermitte F; Rosa A; Comoy E; Bohuon C
Rev Neurol (Paris); 1973 Dec; 129(6):313-24. PubMed ID: 4794176
[No Abstract] [Full Text] [Related]
10. Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?
Barjon P; Fourcade J; Mimran A; Charra B
Rev Eur Etud Clin Biol; 1972 Feb; 17(2):187-92. PubMed ID: 5055013
[No Abstract] [Full Text] [Related]
11. L-dopa and parkinsonism.
Okihiro MM
Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
[No Abstract] [Full Text] [Related]
12. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE
Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744
[No Abstract] [Full Text] [Related]
13. [Treatment of parkinsonism with L-dopa].
Chouza C; Marín C; Romero S; Gomensoro JB
Acta Neurol Latinoam; 1970; 16(1):170-83. PubMed ID: 5538052
[No Abstract] [Full Text] [Related]
14. [Treatment of parkinsonism with L-dopa].
Hernández Peniche J; Martínez Villar C; De León Charles C
Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336
[No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's disease with L-dopa].
Guglielmi L; Vecchi L
Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
[No Abstract] [Full Text] [Related]
16. [Action of L-dopa in Parkinson's syndrome].
Ucar S; Eiras J
Rev Clin Esp; 1971 Feb; 120(3):257-62. PubMed ID: 5568474
[No Abstract] [Full Text] [Related]
17. [L-dopa in Parkinson's syndrome].
Filho RM; de Karam GM
Rev Bras Med; 1971 May; 28(5):220-31. PubMed ID: 5563096
[No Abstract] [Full Text] [Related]
18. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
Dumas R; Rahme M; Schott B
J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571
[No Abstract] [Full Text] [Related]
19. Side effects of L-dopa treatment.
Greenburg J
Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645
[No Abstract] [Full Text] [Related]
20. [L-DOPA therapy of parkinsonism].
Refsum S
Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
